InnovAge Holding (INNV) Q2 2026 earnings — TrendMatrix coverage

Reported EPS

$0.10

Estimate

$0.08

Surprise

+29.3%

Revenue (period 2026-06-30)

$262.0M

Score today

6.2/10

Revenue source: xbrl.

InnovAge Holding (INNV) beat the $0.08 estimate with diluted EPS of $0.10 — a large 29.3% upside surprise.

• Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday — benzinga, 2026-09-10
• Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday — benzinga, 2026-09-09
• Keybanc Maintains Overweight on InnovAge Holding, Raises Price Target to $14 — benzinga, 2026-09-09

TrendMatrix currently rates INNV Sell at 6.2/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +29.3% surprise compares with a +123.5% four-quarter average. Next scheduled report: 2026-11-03.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$10.70

Price target

$11.96

Stop

$10.00

Upside to target

+11.8%

Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Care Facilities

Market cap

$1.47B

P/E (fwd)

21.5

52-week range

$3.94–$12.64

Off 52-week high

15.3%

RSI (14)

45

Volume vs avg

0.78×

Score today

6.2/10